1. Home
  2. ALLO vs NMCO Comparison

ALLO vs NMCO Comparison

Compare ALLO & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$0.76

Market Cap

452.6M

Sector

Health Care

ML Signal

HOLD

Logo Nuveen Municipal Credit Opportunities Fund

NMCO

Nuveen Municipal Credit Opportunities Fund

SELL

Current Price

$8.50

Market Cap

538.1M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
ALLO
NMCO
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
452.6M
538.1M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
ALLO
NMCO
Price
$0.76
$8.50
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
★ $9.00
N/A
AVG Volume (30 Days)
★ 11.2M
582.7K
Earning Date
11-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 34.09
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$72.02
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.74
$8.33
52 Week High
$4.46
$11.00

Technical Indicators

Market Signals
Indicator
ALLO
NMCO
Relative Strength Index (RSI) 21.26 34.67
Support Level N/A $8.33
Resistance Level $2.25 $10.89
Average True Range (ATR) 0.10 0.14
MACD -0.02 -0.03
Stochastic Oscillator 0.42 1.41

Price Performance

Historical Comparison
ALLO
NMCO

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

About NMCO Nuveen Municipal Credit Opportunities Fund

Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.

Share on Social Networks: